Molecular Neurobiology

, Volume 37, Issue 2–3, pp 142–152 | Cite as

Immune-To-Brain Signaling: How Important are the Blood–Brain Barrier-independent Pathways?

Article

Abstract

A conceptual obstacle for understanding immune-to-brain signaling is the issue of the blood–brain barrier (BBB). In the last 30 years, several pathways have been investigated to address the question of how peripheral immune signals are transmitted into the brain. These pathways can be categorized into two types: BBB-dependent pathways and BBB-independent pathways. BBB-dependent pathways involve the BBB as a relay station or porous barrier, whereas BBB-independent pathways use neuronal routes that bypass the BBB. Recently, a complete BBB-dependent ascending pathway for immune-to-brain signaling has been described. Details of BBB-independent pathways are still under construction. In this review, I will summarize the current progress in unraveling immune-to-brain signaling pathways. In addition, I will provide a critical analysis of the literature to point to areas where our knowledge of the immunological afferent signaling to the central nervous system is still sorely lacking.

Keywords

Neuroimmune communication Cytokine Sickness behavior 

References

  1. 1.
    Plata-Salaman CR, Borkoski JP (1993) Centrally administered bacterial lipopolysaccharide depresses feeding in rats. Pharmacol Biochem Behav 46(4):787–791PubMedGoogle Scholar
  2. 2.
    Foca A, Nicoletta P, Matera G, Mastroeni P, Caputi AP (1983) Antidipsogenic effect of endotoxin in the rat. Circ Shock 11(4):341–350PubMedGoogle Scholar
  3. 3.
    Krueger JM, Majde JA (1995) Cytokines and sleep. Int Arch Allergy Immunol 106(2):97–100PubMedGoogle Scholar
  4. 4.
    Eskay RL, Grino M, Chen HT (1990) Interleukins, signal transduction, and the immune system-mediated stress response. Adv Exp Med Biol 274:331–343PubMedGoogle Scholar
  5. 5.
    Tracey KJ (2002) The inflammatory reflex. Nature 420(6917):853–859PubMedGoogle Scholar
  6. 6.
    Kluger MJ, Ringler DH, Anver MR (1975) Fever and survival. Science 188(4184):166–168PubMedGoogle Scholar
  7. 7.
    Bovbjerg D, Ader R, Cohen N (1982) Behaviorally conditioned suppression of a graft-versus-host response. Proc Natl Acad Sci USA 79(2):583–585PubMedGoogle Scholar
  8. 8.
    Bovbjerg D, Cohen N, Ader R (1987) Behaviorally conditioned enhancement of delayed-type hypersensitivity in the mouse. Brain Behav Immun 1(1):64–71PubMedGoogle Scholar
  9. 9.
    Alisjahbana B, Netea MG, van der Meer JW (2003) Pro-inflammatory cytokine response in acute infection. Adv Exp Med Biol 531:229–240PubMedGoogle Scholar
  10. 10.
    Ching S, Zhang H, Belevych N et al (2007) Endothelial-specific knockdown of interleukin-1 (IL-1) type 1 receptor differentially alters CNS responses to IL-1 depending on its route of administration. J Neurosci 27(39):10476–10486PubMedGoogle Scholar
  11. 11.
    Lesnikov VA, Efremov OM, Korneva EA, Van Damme J, Billiau A (1991) Fever produced by intrahypothalamic injection of interleukin-1 and interleukin-6. Cytokine 3(3):195–198PubMedGoogle Scholar
  12. 12.
    Dinarello CA, Cannon JG, Mancilla J, Bishai I, Lees J, Coceani F (1991) Interleukin-6 as an endogenous pyrogen: induction of prostaglandin E2 in brain but not in peripheral blood mononuclear cells. Brain Res 562(2):199–206PubMedGoogle Scholar
  13. 13.
    Sherman ML, Spriggs DR, Arthur KA, Imamura K, Frei E 3rd, Kufe DW (1988) Recombinant human tumor necrosis factor administered as a five-day continuous infusion in cancer patients: phase I toxicity and effects on lipid metabolism. J Clin Oncol 6(2):344–350PubMedGoogle Scholar
  14. 14.
    Kakucska I, Qi Y, Clark BD, Lechan RM (1993) Endotoxin-induced corticotropin-releasing hormone gene expression in the hypothalamic paraventricular nucleus is mediated centrally by interleukin-1. Endocrinology 133(2):815–821PubMedGoogle Scholar
  15. 15.
    Imeri L, Opp MR, Krueger JM (1993) An IL-1 receptor and an IL-1 receptor antagonist attenuate muramyl dipeptide- and IL-1-induced sleep and fever. Am J Physiol 265(4 Pt 2):R907–R913PubMedGoogle Scholar
  16. 16.
    Lang CH, Cooney R, Vary TC (1996) Central interleukin-1 partially mediates endotoxin-induced changes in glucose metabolism. Am J Physiol 271(2 Pt 1):E309–E316PubMedGoogle Scholar
  17. 17.
    Blatteis CM, Bealer SL, Hunter WS, Llanos QJ, Ahokas RA, Mashburn TA Jr (1983) Suppression of fever after lesions of the anteroventral third ventricle in guinea pigs. Brain Res Bull 11(5):519–526PubMedGoogle Scholar
  18. 18.
    Elmquist JK, Scammell TE, Jacobson CD, Saper CB (1996) Distribution of Fos-like immunoreactivity in the rat brain following intravenous lipopolysaccharide administration. J Comp Neurol 371(1):85–103PubMedGoogle Scholar
  19. 19.
    Stitt JT (1985) Evidence for the involvement of the organum vasculosum laminae terminalis in the febrile response of rabbits and rats. J Physiol 368:501–511PubMedGoogle Scholar
  20. 20.
    Takahashi Y, Smith P, Ferguson A, Pittman QJ (1997) Circumventricular organs and fever. Am J Physiol 273(5 Pt 2):R1690–R1695PubMedGoogle Scholar
  21. 21.
    Lee HY, Whiteside MB, Herkenham M (1998) Area postrema removal abolishes stimulatory effects of intravenous interleukin-1beta on hypothalamic-pituitary-adrenal axis activity and c- fos mRNA in the hypothalamic paraventricular nucleus. Brain Res Bull 46(6):495–503PubMedGoogle Scholar
  22. 22.
    Ericsson A, Arias C, Sawchenko PE (1997) Evidence for an intramedullary prostaglandin-dependent mechanism in the activation of stress-related neuroendocrine circuitry by intravenous interleukin-1. J Neurosci 17(18):7166–7179PubMedGoogle Scholar
  23. 23.
    Romanovsky AA, Sugimoto N, Simons CT, Hunter WS (2003) The organum vasculosum laminae terminalis in immune-to-brain febrigenic signaling: a reappraisal of lesion experiments. Am J Physiol Regul Integr Comp Physiol 285(2):R420–R428PubMedGoogle Scholar
  24. 24.
    Peruzzo B, Pastor FE, Blazquez JL et al (2000) A second look at the barriers of the medial basal hypothalamus. Exp Brain Res 132(1):10–26PubMedGoogle Scholar
  25. 25.
    Breder CD, Hazuka C, Ghayur T et al (1994) Regional induction of tumor necrosis factor alpha expression in the mouse brain after systemic lipopolysaccharide administration. Proc Natl Acad Sci USA 91(24):11393–11397PubMedGoogle Scholar
  26. 26.
    Nakamori T, Morimoto A, Yamaguchi K, Watanabe T, Long NC, Murakami N (1993) Organum vasculosum laminae terminalis (OVLT) is a brain site to produce interleukin-1 beta during fever. Brain Res 618(1):155–159PubMedGoogle Scholar
  27. 27.
    Vallieres L, Rivest S (1997) Regulation of the genes encoding interleukin-6, its receptor, and gp130 in the rat brain in response to the immune activator lipopolysaccharide and the proinflammatory cytokine interleukin-1beta. J Neurochem 69(4):1668–1683PubMedCrossRefGoogle Scholar
  28. 28.
    Nadeau S, Rivest S (1999) Regulation of the gene encoding tumor necrosis factor alpha (TNF-alpha) in the rat brain and pituitary in response in different models of systemic immune challenge. J Neuropathol Exp Neurol 58(1):61–77PubMedGoogle Scholar
  29. 29.
    Quan N, Whiteside M, Herkenham M (1998) Time course and localization patterns of interleukin-1b messenger RNA expression in brain and pituitary after peripheral administration of lipopolysaccharide. Neuroscience 83:281–293PubMedGoogle Scholar
  30. 30.
    Ericsson A, Liu C, Hart RP, Sawchenko PE (1995) Type 1 interleukin-1 receptor in the rat brain: distribution, regulation, and relationship to sites of IL-1-induced cellular activation. J Comp Neurol 361(4):681–698PubMedGoogle Scholar
  31. 31.
    Laflamme N, Rivest S (2001) Toll-like receptor 4: the missing link of the cerebral innate immune response triggered by circulating Gram-negative bacterial cell wall components. FASEB J 15(1):155–163PubMedGoogle Scholar
  32. 32.
    Rivest S (2003) Molecular insights on the cerebral innate immune system. Brain Behav Immun 17(1):13–19PubMedGoogle Scholar
  33. 33.
    Lacroix S, Feinstein D, Rivest S (1998) The bacterial endotoxin lipopolysaccharide has the ability to target the brain in upregulating its membrane CD14 receptor within specific cellular populations. Brain Pathol 8(4):625–640PubMedGoogle Scholar
  34. 34.
    Quan N, Whiteside M, Kim L, Herkenham M (1997) Induction of inhibitory factor kBa mRNA in the central nervous system after peripheral lipopolysaccharide administration: an in situ hybridization histochemistry study in the rat. Proc Natl Acad Sci USA 94:10985–10990PubMedGoogle Scholar
  35. 35.
    Harre EM, Roth J, Gerstberger R, Hubschle T (2003) Interleukin-6 mediates lipopolysaccharide-induced nuclear STAT3 translocation in astrocytes of rat sensory circumventricular organs. Brain Res 980(1):151–155PubMedGoogle Scholar
  36. 36.
    McKinley MJ, Hards DK, Oldfield BJ (1994) Identification of neural pathways activated in dehydrated rats by means of Fos-immunohistochemistry and neural tracing. Brain Res 653(1–2):305–314PubMedGoogle Scholar
  37. 37.
    Larsen PJ, Mikkelsen JD (1995) Functional identification of central afferent projections conveying information of acute “stress” to the hypothalamic paraventricular nucleus. J Neurosci 15(4):2609–2627PubMedGoogle Scholar
  38. 38.
    Silverman AJ, Hoffman DL, Zimmerman EA (1981) The descending afferent connections of the paraventricular nucleus of the hypothalamus (PVN). Brain Res Bull 6(1):47–61PubMedGoogle Scholar
  39. 39.
    Ciriello J, Gutman MB (1991) Functional identification of central pressor pathways originating in the subfornical organ. Can J Physiol Pharmacol 69(7):1035–1045PubMedGoogle Scholar
  40. 40.
    Cottrell GT, Ferguson AV (2004) Sensory circumventricular organs: central roles in integrated autonomic regulation. Regul Pept 117(1):11–23PubMedGoogle Scholar
  41. 41.
    Banks WA, Kastin AJ, Broadwell RD (1995) Passage of cytokines across the blood–brain barrier. Neuroimmunomodulation 2:241–248PubMedGoogle Scholar
  42. 42.
    Banks WA, Kastin AJ (1997) Relative contributions of peripheral and central sources to levels of IL-1 alpha in the cerebral cortex of mice: assessment with species- specific enzyme immunoassays. J Neuroimmunol 79(1):22–28PubMedGoogle Scholar
  43. 43.
    Pan W, Kastin AJ (2002) TNFa transport across the blood–brain barrier is abolished in receptor knockout mice. Exp Neurol 174:193–200PubMedGoogle Scholar
  44. 44.
    Banks WA, Farr SA, La Scola ME, Morley JE (2001) Intravenous human interleukin-1alpha impairs memory processing in mice: dependence on blood–brain barrier transport into posterior division of the septum. J Pharmacol Exp Ther 299(2):536–541PubMedGoogle Scholar
  45. 45.
    Quan N, Banks WA (2007) Brain-immune communication pathways. Brain Behav Immun 21(6):727–735PubMedGoogle Scholar
  46. 46.
    Cunningham ETJ, Wada E, Carter DB, Tracey DE, Battey JF, De Souza EB (1992) In situ histochemical localization of type I interleukin-1 receptor messenger RNA in the central nervous system, pituitary, and adrenal gland of the mouse. J Neurosci 12(3):1101–1114PubMedGoogle Scholar
  47. 47.
    Van Dam AM, De Vries HE, Kuiper J et al (1996) Interleukin-1 receptors on rat brain endothelial cells: a role in neuroimmune interaction? FASEB J 10(2):351–356PubMedGoogle Scholar
  48. 48.
    Konsman JP, Vigues S, Mackerlova L, Bristow A, Blomqvist A (2004) Rat brain vascular distribution of interleukin-1 type-1 receptor immunoreactivity: relationship to patterns of inducible cyclooxygenase expression by peripheral inflammatory stimuli. J Comp Neurol 472(1):113–129PubMedGoogle Scholar
  49. 49.
    Bebo BF Jr, Linthicum DS (1995) Expression of mRNA for 55-kDa and 75-kDa tumor necrosis factor (TNF) receptors in mouse cerebrovascular endothelium: effects of interleukin-1 beta, interferon-gamma and TNF-alpha on cultured cells. J Neuroimmunol 62(2):161–167PubMedGoogle Scholar
  50. 50.
    Vallieres L, Rivest S (1999) Interleukin-6 is a needed proinflammatory cytokine in the prolonged neural activity and transcriptional activation of corticotropin-releasing factor during endotoxemia. Endocrinology 140(9):3890–3903PubMedGoogle Scholar
  51. 51.
    Rummel C, Voss T, Matsumura K et al (2005) Nuclear STAT3 translocation in guinea pig and rat brain endothelium during systemic challenge with lipopolysaccharide and interleukin-6. J Comp Neurol 491(1):1–14PubMedGoogle Scholar
  52. 52.
    Quan N, He L, Lai W (2003) Endothelial activation is an intermediate step for peripheral lipopolysaccharide induced activation of paraventricular nucleus. Brain Res Bull 59(6):447–452PubMedGoogle Scholar
  53. 53.
    Sanchez-Alavez M, Tabarean IV, Behrens MM, Bartfai T (2006) Ceramide mediates the rapid phase of febrile response to IL-1beta. Proc Natl Acad Sci USA 103(8):2904–2908PubMedGoogle Scholar
  54. 54.
    Quan N, Whiteside M, Herkenham M (1998) Cyclooxygenase 2 mRNA expression in rat brain after peripheral injection of lipopolysaccharide. Brain Res 802(1–2):189–197PubMedGoogle Scholar
  55. 55.
    Cao C, Matsumura K, Yamagata K, Watanabe Y (1997) Involvement of cyclooxygenase-2 in LPS-induced fever and regulation of its mRNA by LPS in the rat brain. Am J Physiol 272(6 Pt 2):R1712–R1725PubMedGoogle Scholar
  56. 56.
    Engblom D, Saha S, Engstrom L et al (2003) Microsomal prostaglandin E synthase-1 is the central switch during immune-induced pyresis. Nat Neurosci 6(11):1137–1138PubMedGoogle Scholar
  57. 57.
    Ek M, Engblom D, Saha S, Blomqvist A, Jakobsson PJ, Ericsson-Dahlstrand A (2001) Inflammatory response: pathway across the blood–brain barrier. Nature 410(6827):430–431PubMedGoogle Scholar
  58. 58.
    Yamagata K, Matsumura K, Inoue W et al (2001) Coexpression of microsomal-type prostaglandin E synthase with cyclooxygenase-2 in brain endothelial cells of rats during endotoxin-induced fever. J Neurosci 21(8):2669–2677PubMedGoogle Scholar
  59. 59.
    Lazarus M, Yoshida K, Coppari R et al (2007) EP3 prostaglandin receptors in the median preoptic nucleus are critical for fever responses. Nat Neurosci 10(9):1131–1133PubMedGoogle Scholar
  60. 60.
    Gosselin D, Rivest S (2008) MyD88 signaling in brain endothelial cells is essential for the neuronal activity and glucocorticoid release during systemic inflammation. Mol Psychiatry 13:480–497PubMedGoogle Scholar
  61. 61.
    Steiner AA, Chakravarty S, Rudaya AY, Herkenham M, Romanovsky AA (2006) Bacterial lipopolysaccharide fever is initiated via Toll-like receptor 4 on hematopoietic cells. Blood 107(10):4000–4002PubMedGoogle Scholar
  62. 62.
    Schiltz JC, Sawchenko PE (2002) Distinct brain vascular cell types manifest inducible cyclooxygenase expression as a function of the strength and nature of immune insults. J Neurosci 22(13):5606–5618PubMedGoogle Scholar
  63. 63.
    Wiik H, Karttunen R, Haukipuro K, Syrjala H (2001) Maximal local and minimal systemic cytokine response to colorectal surgery: the influence of perioperative filgrastim. Cytokine 14(3):188–192PubMedGoogle Scholar
  64. 64.
    Yamamoto T, Umegae S, Kitagawa T, Matsumoto K (2005) Systemic and local cytokine production in quiescent ulcerative colitis and its relationship to future relapse: a prospective pilot study. Inflamm Bowel Dis 11(6):589–596PubMedGoogle Scholar
  65. 65.
    Hedges SR, Barrientes F, Desmond RA, Schwebke JR (2006) Local and systemic cytokine levels in relation to changes in vaginal flora. J Infect Dis 193(4):556–562PubMedGoogle Scholar
  66. 66.
    Cavaillon JM, Annane D (2006) Compartmentalization of the inflammatory response in sepsis and SIRS. J Endotoxin Res 12(3):151–170PubMedGoogle Scholar
  67. 67.
    Makhija R, Kingsnorth AN (2002) Cytokine storm in acute pancreatitis. J Hepatobiliary Pancreat Surg 9(4):401–410PubMedGoogle Scholar
  68. 68.
    O’Nuallain EM, Puri P, Mealy K, Reen DJ (1995) Induction of interleukin-1 receptor antagonist (IL-1ra) following surgery is associated with major trauma. Clin Immunol Immunopathol 76(1 Pt 1):96–101PubMedGoogle Scholar
  69. 69.
    Cavaillon JM, Adib-Conquy M, Fitting C, Adrie C, Payen D (2003) Cytokine cascade in sepsis. Scand J Infect Dis 35(9):535–544PubMedGoogle Scholar
  70. 70.
    Munford RS, Pugin J (2001) Normal responses to injury prevent systemic inflammation and can be immunosuppressive. Am J Respir Crit Care Med 163(2):316–321PubMedGoogle Scholar
  71. 71.
    Creasey AA, Stevens P, Kenney J et al (1991) Endotoxin and cytokine profile in plasma of baboons challenged with lethal and sublethal Escherichia coli. Circ Shock 33(2):84–91PubMedGoogle Scholar
  72. 72.
    Anthony DC, Bolton SJ, Fearn S, Perry VH (1997) Age-related effects of interleukin-1 beta on polymorphonuclear neutrophil-dependent increases in blood–brain barrier permeability in rats. Brain 120(Pt 3):435–444PubMedGoogle Scholar
  73. 73.
    Ching S, He L, Lai W, Quan N (2005) IL-1 type I receptor plays a key role in mediating the recruitment of leukocytes into the central nervous system. Brain Behav Immun 19(2):127–137PubMedGoogle Scholar
  74. 74.
    Nadeau S, Rivest S (2002) Endotoxemia prevents the cerebral inflammatory wave induced by intraparenchymal lipopolysaccharide injection: role of glucocorticoids and CD14. J Immunol 169(6):3370–3381PubMedGoogle Scholar
  75. 75.
    Ching S, Zhang H, Lai W, Quan N (2006) Peripheral injection of lipopolysaccharide prevents brain recruitment of leukocytes induced by central injection of interleukin-1. Neuroscience 137(2):717–726PubMedGoogle Scholar
  76. 76.
    McColl BW, Rothwell NJ, Allan SM (2007) Systemic inflammatory stimulus potentiates the acute phase and CXC chemokine responses to experimental stroke and exacerbates brain damage via interleukin-1- and neutrophil-dependent mechanisms. J Neurosci 27(16):4403–4412PubMedGoogle Scholar
  77. 77.
    Cunningham C, Wilcockson DC, Campion S, Lunnon K, Perry VH (2005) Central and systemic endotoxin challenges exacerbate the local inflammatory response and increase neuronal death during chronic neurodegeneration. J Neurosci 25(40):9275–9284PubMedGoogle Scholar
  78. 78.
    Romanovsky AA (2004) Signaling the brain in the early sickness syndrome: are sensory nerves involved? Front Biosci 9:494–504PubMedGoogle Scholar
  79. 79.
    Bluthe RM, Walter V, Parnet P et al (1994) Lipopolysaccharide induces sickness behaviour in rats by a vagal mediated mechanism. C R Acad Sci Ser III 317(6):499–503PubMedGoogle Scholar
  80. 80.
    Watkins LR, Wiertelak EP, Goehler LE, Smith KP, Martin D, Maier SF (1994) Characterization of cytokine-induced hyperalgesia. Brain Res 654(1):15–26PubMedGoogle Scholar
  81. 81.
    Maier SF, Goehler LE, Fleshner M, Watkins LR (1998) The role of the vagus nerve in cytokine-to-brain communication. Ann N Y Acad Sci 840:289–300PubMedGoogle Scholar
  82. 82.
    Sehic E, Blatteis CM (1996) Blockade of lipopolysaccharide-induced fever by subdiaphragmatic vagotomy in guinea pigs. Brain Res 726(1–2):160–166PubMedGoogle Scholar
  83. 83.
    Watkins LR, Goehler LE, Relton JK et al (1995) Blockade of interleukin-1 induced hyperthermia by subdiaphragmatic vagotomy: evidence for vagal mediation of immune-brain communication. Neurosci Lett 183(1–2):27–31PubMedGoogle Scholar
  84. 84.
    Hansen MK, O’Connor KA, Goehler LE, Watkins LR, Maier SF (2001) The contribution of the vagus nerve in interleukin-1beta-induced fever is dependent on dose. Am J Physiol Regul Integr Comp Physiol 280(4):R929–R934PubMedGoogle Scholar
  85. 85.
    Romanovsky AA, Simons CT, Szekely M, Kulchitsky VA (1997) The vagus nerve in the thermoregulatory response to systemic inflammation. Am J Physiol 273(1 Pt 2):R407–R413PubMedGoogle Scholar
  86. 86.
    Luheshi GN, Bluthe RM, Rushforth D et al (2000) Vagotomy attenuates the behavioural but not the pyrogenic effects of interleukin-1 in rats. Auton Neurosci 85(1–3):127–132PubMedGoogle Scholar
  87. 87.
    Bret-Dibat JL, Bluthe RM, Kent S, Kelley KW, Dantzer R (1995) Lipopolysaccharide and interleukin-1 depress food-motivated behavior in mice by a vagal-mediated mechanism. Brain Behav Immun 9(3):242–246PubMedGoogle Scholar
  88. 88.
    Porter MH, Hrupka BJ, Langhans W, Schwartz GJ (1998) Vagal and splanchnic afferents are not necessary for the anorexia produced by peripheral IL-1beta, LPS, and MDP. Am J Physiol 275(2 Pt 2):R384–R389PubMedGoogle Scholar
  89. 89.
    Wieczorek M, Swiergiel AH, Pournajafi-Nazarloo H, Dunn AJ (2005) Physiological and behavioral responses to interleukin-1beta and LPS in vagotomized mice. Physiol Behav 85(4):500–511PubMedGoogle Scholar
  90. 90.
    Fleshner M, Goehler LE, Hermann J, Relton JK, Maier SF, Watkins LR (1995) Interleukin-1 beta induced corticosterone elevation and hypothalamic NE depletion is vagally mediated. Brain Res Bull 37(6):605–610PubMedGoogle Scholar
  91. 91.
    MohanKumar SM, MohanKumar PS, Quadri SK (2000) Effects of bacterial lipopolysaccharide on central monoamines and fever in the rat: involvement of the vagus. Neurosci Lett 284(3):159–162PubMedGoogle Scholar
  92. 92.
    Wieczorek M, Dunn AJ (2006) Effect of subdiaphragmatic vagotomy on the noradrenergic and HPA axis activation induced by intraperitoneal interleukin-1 administration in rats. Brain Res 1101(1):73–84PubMedGoogle Scholar
  93. 93.
    Ootsuka Y, Blessing WW, Steiner AA, Romanovsky AA (2008) Fever response to intravenous prostaglandin E2 is mediated by the brain but does not require afferent vagal signaling. Am J Physiol Regul Integr Comp Physiol 294(4):R1294–R1303PubMedGoogle Scholar
  94. 94.
    Laye S, Bluthe RM, Kent S et al (1995) Subdiaphragmatic vagotomy blocks induction of IL-1 beta mRNA in mice brain in response to peripheral LPS. Am J Physiol 268(5 Pt 2):R1327–R1331PubMedGoogle Scholar
  95. 95.
    Hansen MK, Taishi P, Chen Z, Krueger JM (1998) Vagotomy blocks the induction of interleukin-1beta (IL-1beta) mRNA in the brain of rats in response to systemic IL-1beta. J Neurosci 18(6):2247–2253PubMedGoogle Scholar
  96. 96.
    Hansen MK, Nguyen KT, Goehler LE et al (2000) Effects of vagotomy on lipopolysaccharide-induced brain interleukin-1beta protein in rats. Auton Neurosci 85(1–3):119–126PubMedGoogle Scholar
  97. 97.
    van Dam A-M, Brouns M, Louisse S, Berkenbosch F (1992) Appearance of interleukin-1 in macrophages and in ramified microglia in the brain of endotoxin-treated rats: a pathway for the induction of non-specific symptoms of sickness? Brain Res 588:291–296PubMedGoogle Scholar
  98. 98.
    Proescholdt MG, Chakravarty S, Foster JA, Foti SB, Briley EM, Herkenham M (2002) Intracerebroventricular but not intravenous interleukin-1beta induces widespread vascular-mediated leukocyte infiltration and immune signal mRNA expression followed by brain-wide glial activation. Neuroscience 112(3):731–749PubMedGoogle Scholar
  99. 99.
    Goehler LE, Gaykema RP, Opitz N, Reddaway R, Badr N, Lyte M (2005) Activation in vagal afferents and central autonomic pathways: early responses to intestinal infection with Campylobacter jejuni. Brain Behav Immun 19(4):334–344PubMedGoogle Scholar
  100. 100.
    Campisi J, Hansen MK, O’Connor KA et al (2003) Circulating cytokines and endotoxin are not necessary for the activation of the sickness or corticosterone response produced by peripheral E. coli challenge. J Appl Physiol 95(5):1873–1882PubMedGoogle Scholar
  101. 101.
    Blatteis CM (2007) The onset of fever: new insights into its mechanism. Prog Brain Res 162:3–14PubMedCrossRefGoogle Scholar
  102. 102.
    Blatteis CM, Li S, Li Z, Perlik V, Feleder C (2004) Signaling the brain in systemic inflammation: the role of complement. Front Biosci 9:915–931PubMedGoogle Scholar
  103. 103.
    Blatteis CM (2006) Endotoxic fever: new concepts of its regulation suggest new approaches to its management. Pharmacol Ther 111(1):194–223PubMedGoogle Scholar
  104. 104.
    Simons CT, Kulchitsky VA, Sugimoto N, Homer LD, Szekely M, Romanovsky AA (1998) Signaling the brain in systemic inflammation: which vagal branch is involved in fever genesis? Am J Physiol 275(1 Pt 2):R63–R68PubMedGoogle Scholar
  105. 105.
    Steiner AA, Ivanov AI, Serrats J et al (2006) Cellular and molecular bases of the initiation of fever. PLoS Biol 4(9):e284PubMedGoogle Scholar
  106. 106.
    Cartmell T, Poole S, Turnbull AV, Rothwell NJ, Luheshi GN (2000) Circulating interleukin-6 mediates the febrile response to localised inflammation in rats. J Physiol 526(Pt 3):653–661PubMedGoogle Scholar
  107. 107.
    Miller AJ, Hopkins SJ, Luheshi GN (1997) Sites of action of IL-1 in the development of fever and cytokine responses to tissue inflammation in the rat. Br J Pharmacol 120(7):1274–1279PubMedGoogle Scholar
  108. 108.
    Kozak W, Kluger MJ, Soszynski D et al (1998) IL-6 and IL-1 beta in fever. Studies using cytokine-deficient (knockout) mice. Ann NY Acad Sci 856:33–47PubMedGoogle Scholar
  109. 109.
    Roth J, De Souza GE (2001) Fever induction pathways: evidence from responses to systemic or local cytokine formation. Braz J Med Biol Res 34(3):301–314PubMedGoogle Scholar
  110. 110.
    Rummel C, Barth SW, Voss T et al (2005) Localized vs. systemic inflammation in guinea pigs: a role for prostaglandins at distinct points of the fever induction pathways? Am J Physiol Regul Integr Comp Physiol 289(2):R340–R347PubMedGoogle Scholar
  111. 111.
    Cooper AL, Rothwell NJ (1991) Mechanisms of early and late hypermetabolism and fever after localized tissue injury in rats. Am J Physiol 261(6 Pt 1):E698–E705PubMedGoogle Scholar
  112. 112.
    Goldbach JM, Roth J, Zeisberger E (1997) Fever suppression by subdiaphragmatic vagotomy in guinea pigs depends on the route of pyrogen administration. Am J Physiol 272(2 Pt 2):R675–R681PubMedGoogle Scholar
  113. 113.
    Borovikova LV, Ivanova S, Zhang M et al (2000) Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 405(6785):458–462PubMedGoogle Scholar
  114. 114.
    Lussier A, de Medicis R, Tetreault L (1981) Adjuvant arthritis: influence of the adjuvant volume and composition on the non-specific inflammation. Int J Tissue React 3(1):11–15PubMedGoogle Scholar
  115. 115.
    Connolly KM, Stecher VJ, Danis E, Pruden DJ, LaBrie T (1988) Alteration of interleukin-1 production and the acute phase response following medication of adjuvant arthritic rats with cyclosporin-A or methotrexate. Int J Immunopharmacol 10(6):717–728PubMedGoogle Scholar
  116. 116.
    Eski M, Sahin I, Sengezer M, Serdar M, Ifran A (2008) Thalidomide decreases the plasma levels of IL-1 and TNF following burn injury: is it a new drug for modulation of systemic inflammatory response. Burns 34(1):104–108PubMedGoogle Scholar
  117. 117.
    Engblom D, Ek M, Andersson IM et al (2002) Induction of microsomal prostaglandin E synthase in the rat brain endothelium and parenchyma in adjuvant-induced arthritis. J Comp Neurol 452(3):205–214PubMedGoogle Scholar
  118. 118.
    Ozaki-Okayama Y, Matsumura K, Ibuki T et al (2004) Burn injury enhances brain prostaglandin E2 production through induction of cyclooxygenase-2 and microsomal prostaglandin E synthase in cerebral vascular endothelial cells in rats. Crit Care Med 32(3):795–800PubMedGoogle Scholar
  119. 119.
    Saha S, Engstrom L, Mackerlova L, Jakobsson PJ, Blomqvist A (2005) Impaired febrile responses to immune challenge in mice deficient in microsomal prostaglandin E synthase-1. Am J Physiol Regul Integr Comp Physiol 288(5):R1100–R1107PubMedGoogle Scholar
  120. 120.
    Oka Y, Ibuki T, Matsumura K et al (2007) Interleukin-6 is a candidate molecule that transmits inflammatory information to the CNS. Neuroscience 145(2):530–538PubMedGoogle Scholar
  121. 121.
    Guay J, Bateman K, Gordon R, Mancini J, Riendeau D (2004) Carrageenan-induced paw edema in rat elicits a predominant prostaglandin E2 (PGE2) response in the central nervous system associated with the induction of microsomal PGE2 synthase-1. J Biol Chem 279(23):24866–24872PubMedGoogle Scholar

Copyright information

© Humana Press Inc. 2008

Authors and Affiliations

  1. 1.Institute of Behavior MedicineOhio State UniversityColumbusUSA

Personalised recommendations